Retroviral vector-mediated gene transfer and expression in nonhuman primates following autologous bone marrow transplantation

A. Gillio, C. Bordignon, N. Kernan, P. Kantoff, M. Eglitis, J. McLachlin, E. Karson, S. F. Yu, J. Zwiebel, A. Nienhuis, S. Karlsson, M. Blaese, D. Kohn, D. Armentano, Eli Gilboa, W. F. Anderson, R. J. O'Reilly

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

We have demonstrated in a large animal model the potential of SAX vector-infected autologous marrow to reconstitute the hematopoietic systems of lethally irradiated animals. We have begun to define in-vitro conditions to optimize SAX-vector infection of primate cells. The supernatant method of marrow infection produced the highest efficiency of CFU-C infection, and in addition, reinfusion of supernatant-infected marrow resulted in the most prompt and complete hematopoietic reconstruction. Most importantly, we have shown evidence of transfer and expression of a foreign gene (h-ADA) in 4 of 5 reconstituted primates for up to 120 days posttransplant. This study demonstrates the feasibility of retroviral-mediated gene transfer to correct ADA deficiency. However, it points out two major problems that must be solved if it is to be successful: 1) the low frequency of gene transfer into hematopoietic cells and 2) the loss of expression of successfully transferred genes. We are approaching the former problem in two ways, first, by modifying in-vitro infection conditions, such as increasing viral to target cell ratios and second, by manipulating marrow progenitors in vivo prior to explanation to increase the cycling pool of stem and/or committed progenitors. Increasing vector infection efficiency, should result in a better understanding of the observed loss of gene expression in long-term reconstituted primates.

Original languageEnglish
Pages (from-to)406-417
Number of pages12
JournalAnnals of the New York Academy of Sciences
Volume511
StatePublished - Dec 1 1987
Externally publishedYes

Fingerprint

Gene transfer
Autologous Transplantation
Bone Marrow Transplantation
Gene expression
Primates
Bone
Gene Expression
Bone Marrow
Animals
Genes
Infection
Hematopoietic System
Cells
Feasibility Studies
Gene Frequency
Animal Models
Nonhuman Primate
Transplantation
Gene
Marrow

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Gillio, A., Bordignon, C., Kernan, N., Kantoff, P., Eglitis, M., McLachlin, J., ... O'Reilly, R. J. (1987). Retroviral vector-mediated gene transfer and expression in nonhuman primates following autologous bone marrow transplantation. Annals of the New York Academy of Sciences, 511, 406-417.

Retroviral vector-mediated gene transfer and expression in nonhuman primates following autologous bone marrow transplantation. / Gillio, A.; Bordignon, C.; Kernan, N.; Kantoff, P.; Eglitis, M.; McLachlin, J.; Karson, E.; Yu, S. F.; Zwiebel, J.; Nienhuis, A.; Karlsson, S.; Blaese, M.; Kohn, D.; Armentano, D.; Gilboa, Eli; Anderson, W. F.; O'Reilly, R. J.

In: Annals of the New York Academy of Sciences, Vol. 511, 01.12.1987, p. 406-417.

Research output: Contribution to journalArticle

Gillio, A, Bordignon, C, Kernan, N, Kantoff, P, Eglitis, M, McLachlin, J, Karson, E, Yu, SF, Zwiebel, J, Nienhuis, A, Karlsson, S, Blaese, M, Kohn, D, Armentano, D, Gilboa, E, Anderson, WF & O'Reilly, RJ 1987, 'Retroviral vector-mediated gene transfer and expression in nonhuman primates following autologous bone marrow transplantation', Annals of the New York Academy of Sciences, vol. 511, pp. 406-417.
Gillio, A. ; Bordignon, C. ; Kernan, N. ; Kantoff, P. ; Eglitis, M. ; McLachlin, J. ; Karson, E. ; Yu, S. F. ; Zwiebel, J. ; Nienhuis, A. ; Karlsson, S. ; Blaese, M. ; Kohn, D. ; Armentano, D. ; Gilboa, Eli ; Anderson, W. F. ; O'Reilly, R. J. / Retroviral vector-mediated gene transfer and expression in nonhuman primates following autologous bone marrow transplantation. In: Annals of the New York Academy of Sciences. 1987 ; Vol. 511. pp. 406-417.
@article{99034918fe024525abd5e0df78501ca8,
title = "Retroviral vector-mediated gene transfer and expression in nonhuman primates following autologous bone marrow transplantation",
abstract = "We have demonstrated in a large animal model the potential of SAX vector-infected autologous marrow to reconstitute the hematopoietic systems of lethally irradiated animals. We have begun to define in-vitro conditions to optimize SAX-vector infection of primate cells. The supernatant method of marrow infection produced the highest efficiency of CFU-C infection, and in addition, reinfusion of supernatant-infected marrow resulted in the most prompt and complete hematopoietic reconstruction. Most importantly, we have shown evidence of transfer and expression of a foreign gene (h-ADA) in 4 of 5 reconstituted primates for up to 120 days posttransplant. This study demonstrates the feasibility of retroviral-mediated gene transfer to correct ADA deficiency. However, it points out two major problems that must be solved if it is to be successful: 1) the low frequency of gene transfer into hematopoietic cells and 2) the loss of expression of successfully transferred genes. We are approaching the former problem in two ways, first, by modifying in-vitro infection conditions, such as increasing viral to target cell ratios and second, by manipulating marrow progenitors in vivo prior to explanation to increase the cycling pool of stem and/or committed progenitors. Increasing vector infection efficiency, should result in a better understanding of the observed loss of gene expression in long-term reconstituted primates.",
author = "A. Gillio and C. Bordignon and N. Kernan and P. Kantoff and M. Eglitis and J. McLachlin and E. Karson and Yu, {S. F.} and J. Zwiebel and A. Nienhuis and S. Karlsson and M. Blaese and D. Kohn and D. Armentano and Eli Gilboa and Anderson, {W. F.} and O'Reilly, {R. J.}",
year = "1987",
month = "12",
day = "1",
language = "English",
volume = "511",
pages = "406--417",
journal = "Annals of the New York Academy of Sciences",
issn = "0077-8923",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Retroviral vector-mediated gene transfer and expression in nonhuman primates following autologous bone marrow transplantation

AU - Gillio, A.

AU - Bordignon, C.

AU - Kernan, N.

AU - Kantoff, P.

AU - Eglitis, M.

AU - McLachlin, J.

AU - Karson, E.

AU - Yu, S. F.

AU - Zwiebel, J.

AU - Nienhuis, A.

AU - Karlsson, S.

AU - Blaese, M.

AU - Kohn, D.

AU - Armentano, D.

AU - Gilboa, Eli

AU - Anderson, W. F.

AU - O'Reilly, R. J.

PY - 1987/12/1

Y1 - 1987/12/1

N2 - We have demonstrated in a large animal model the potential of SAX vector-infected autologous marrow to reconstitute the hematopoietic systems of lethally irradiated animals. We have begun to define in-vitro conditions to optimize SAX-vector infection of primate cells. The supernatant method of marrow infection produced the highest efficiency of CFU-C infection, and in addition, reinfusion of supernatant-infected marrow resulted in the most prompt and complete hematopoietic reconstruction. Most importantly, we have shown evidence of transfer and expression of a foreign gene (h-ADA) in 4 of 5 reconstituted primates for up to 120 days posttransplant. This study demonstrates the feasibility of retroviral-mediated gene transfer to correct ADA deficiency. However, it points out two major problems that must be solved if it is to be successful: 1) the low frequency of gene transfer into hematopoietic cells and 2) the loss of expression of successfully transferred genes. We are approaching the former problem in two ways, first, by modifying in-vitro infection conditions, such as increasing viral to target cell ratios and second, by manipulating marrow progenitors in vivo prior to explanation to increase the cycling pool of stem and/or committed progenitors. Increasing vector infection efficiency, should result in a better understanding of the observed loss of gene expression in long-term reconstituted primates.

AB - We have demonstrated in a large animal model the potential of SAX vector-infected autologous marrow to reconstitute the hematopoietic systems of lethally irradiated animals. We have begun to define in-vitro conditions to optimize SAX-vector infection of primate cells. The supernatant method of marrow infection produced the highest efficiency of CFU-C infection, and in addition, reinfusion of supernatant-infected marrow resulted in the most prompt and complete hematopoietic reconstruction. Most importantly, we have shown evidence of transfer and expression of a foreign gene (h-ADA) in 4 of 5 reconstituted primates for up to 120 days posttransplant. This study demonstrates the feasibility of retroviral-mediated gene transfer to correct ADA deficiency. However, it points out two major problems that must be solved if it is to be successful: 1) the low frequency of gene transfer into hematopoietic cells and 2) the loss of expression of successfully transferred genes. We are approaching the former problem in two ways, first, by modifying in-vitro infection conditions, such as increasing viral to target cell ratios and second, by manipulating marrow progenitors in vivo prior to explanation to increase the cycling pool of stem and/or committed progenitors. Increasing vector infection efficiency, should result in a better understanding of the observed loss of gene expression in long-term reconstituted primates.

UR - http://www.scopus.com/inward/record.url?scp=0023610308&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023610308&partnerID=8YFLogxK

M3 - Article

C2 - 2894194

AN - SCOPUS:0023610308

VL - 511

SP - 406

EP - 417

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

ER -